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The human gut microbiota (HGM), which is critical to human health, utilises complex glycans
as its major carbon source. Glycosaminoglycans represent an important, high priority,
nutrient source for the HGM. Pathways for the metabolism of various glycosaminoglycan
substrates remain ill-defined. Here we perform a biochemical, genetic and structural dis-
section of the genetic loci that orchestrates glycosaminoglycan metabolism in the organism
Bacteroides thetaiotaomicron. Here, we report: the discovery of two previously unknown sur-
face glycan binding proteins which facilitate glycosaminoglycan import into the periplasm;
distinct kinetic and genetic specificities of various periplasmic lyases which dictate glycosa-
minoglycan metabolic pathways; understanding of endo sulfatase activity questioning the
paradigm of how the ‘sulfation problem’ is handled by the HGM; and 3D crystal structures of
the polysaccharide utilisation loci encoded sulfatases. Together with comparative genomic
studies, our study fills major gaps in our knowledge of glycosaminoglycan metabolism by
the HGM.
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The human gut microbiota (HGM) is a vast microbialcommunity that is crucial to human health1. The main-tenance of the HGM is dependent on its ability to utilise
complex glycans as a nutrient source, in the form of dietary and
host glycans2. The mechanisms by which this community meta-
bolises these glycans is therefore critical to understanding the
ecology of the system and how it could be manipulated to benefit
human health. Bacteroidetes is one of the two major phyla that
dominate the HGM3. These organisms dedicate up to 20% of
their genome to complex glycan metabolism in the form of genes
primarily encoding carbohydrate active enzymes such as, poly-
saccharide lyases (PLs), glycoside hydrolases, glycan transport
and binding proteins, and carbohydrate sulfatases. Bacteroides
arrange these genes into polysaccharide utilisation loci (PUL)
which are co-localised, co-regulated genes, in response to a spe-
cific glycan4,5. The vast majority of our understanding of how
Bacteroidetes metabolise complex glycans is based on dietary
plant glycans6–9 yet host glycans represent a substantial carbon
reservoir, which is also accessed by the HGM10,11. Glycosami-
noglycans (GAGs) have been demonstrated to be a high-priority
carbon source for the HGM organism Bacteroides thetaiotaomi-
cron (B. theta)11,12, and although a pathway for Heparin/Heparan
sulfate13 (H/HS) has been described, the metabolism of the
complex, and distinct, GAGs chondroitin sulfate (CS-A and
CS-C), dermatan sulfate (DS) and hyaluronic acid (HA) is poorly
described. Enzymes of the HGM that metabolise CS have
been described13–15, yet how they co-ordinate together, their
mechanistic details, mode of action and sulfation tolerances
remain largely opaque. In addition, the role and mechanism of
action of the surface glycan binding proteins (SGBPs) in the
degradation of CS, DS and HA is unknown. Here we report how a
core PUL has evolved to metabolise the complexity and hetero-
geneity of CS-A, CS-C, DS and HA. The PULCS/DS/HA is co-
regulated with distant genes, including a hyaluronidase belonging
to the recently classified PL3316, to complement its core activities
and thus fully enabling multiple GAG breakdown. Crystal
structures of the two PUL-encoded carbohydrate sulfatases pro-
vide key insights into substrate recognition by these critical, and
therapeutically relevant17, enzymes. The data enable a general
model to be proposed for the metabolism of CS, DS and HA by
the HGM and the Bacteroidetes phylum in a wider context.
Results
Structure of CS-A, CS-C, DS and HA. CS-A and CS-C are both
composed of repeating disaccharide units composed of D-glu-
curonic acid (GlcA) and N-acetyl-D-galactosamine (GalNAc).
GlcA is linked β(1,3) to GalNAc which is then linked β(1,4) to the
next GlcA. CS-A and CS-C differ only in sulfation with CS-A
highly enriched in O4 sulfation on GalNAc whilst CS-C is enri-
ched in O6 sulfation on GalNAc. DS is related to CS-A except
GlcA is predominantly replaced with L-iduronic acid which is
connected to GalNAc via an α(1,4) linkage. Finally, HA is similar
to CS-A but replaces GalNAc with N-acetyl-D-glucosamine
(GlcNAc) and contains no sulfation (Fig. 1b).
PULCS/DS/HA structure. B. theta grows on CS-A, CS-C, DS
and HA and transcriptomics, on CS-C and HA, demonstrate
only PULCS/DS/HA and two additional genes, BT1596-S1_92S-sulf
and BT4410PL33 are upregulated4,13. PULCS/DS/HA encodes
three PLs (BT3324PL8, BT3328PL29 and BT3350PL8), one
GH88 (BT3348GH88), 2-O-sulfatases (BT3333-S1_156S-sulf and
BT3349-S1_274S-sulf), a single SusC/D-like transporter system
(BT3331susD-BT3332susC), a hybrid two-component sensor
(BT3334HTCS) and two proteins of unknown function (BT3329
and BT3330). The non-PUL encoded genes, BT1596-S1_92S-sulf
and BT4410PL33, encode a 2-O sulfatase and a hyaluronidase,
respectively (Fig. 1a, b). A paradigm for how PULs organise their
protein apparatus has been established. A surface enzyme(s), with
usually one SGBP, degrades and captures large polysaccharides/
oligosaccharides at the cell surface. These partially degraded poly-
saccharides/oligosaccharides are transported into the periplasm
through the action of the highly conserved, and critical, SusC/D-
like transporter system. Small polysaccharides/large oligosacchar-
ides transported into the periplasm are then metabolised to their
constituent parts, usually monosaccharides, and transported into
the cytoplasm to enter cytoplasmic metabolic pathways.
Extracellular glycan binding and degradation. Two genes of
unknown function BT3329 and BT3330 exist within PULCS/DS/HA.
Both proteins had no enzymatic activity against any GAG sub-
strates. However, they were shown to exhibit binding by iso-
thermal titration calorimetry (ITC). Both proteins were able to
bind all four GAGs and were thus classified as SGBPs (Supple-
mentary Fig. 1 and Supplementary Table 1). BT3329SGBP bound to
CS-A and HA with approximately ten and fourfold higher affinity
than BT3330SGBP whilst against CS-C and DS BT3329SGBP bound
with an ~100 and ~50-fold higher affinity. BT3329SGBP but not
BT3330SGBP bound a CS oligosaccharide of DP10. BT3330SGBP
was, however, able to bind a CS oligosaccharide of DP20. The
SGBPs thus differ in their polysaccharide and oligosaccharide
preferences. BT3329SGBP has the ability to bind more variably
sulfated and smaller glycans than BT3330SGBP, and displays
a greater tolerance to iduronic acid (Supplementary Fig. 1 and
2a). Both proteins were confirmed to be extracellular by immu-
nofluorescence assays (Supplementary Fig. 2b). BT3331susD
demonstrated a very strict substrate specificity binding only to
CS-A with a measurable affinity, similar to that of BT3329SGBP
(Supplementary Table 1). The surface lyase, BT3328PL29, showed
its highest enzymatic activity and affinity against CS-A > CS-C >
HA and little activity on DS, differing from previous data18.
End point assays, the total number of glycosidic bonds cleaved,
followed the relationship of HA > CS-C > CS-A (Fig. 2 and
Supplementary Table 2). This demonstrates that although O4
sulfation increases BT3328PL29 activity on CS-A it also limits
glycosidic bond access in some contexts. BT3328PL29 was only
able to cleave HA oligosaccharides with a DP ≥ 8, indicating the
enzyme has at least eight subsites (Supplementary Fig. 4a).
Interestingly, BT3328PL29 displays very similar substrate specifi-
cities to BT3331susD which, could suggest that the proteins work
closely together at the cell surface. When BT3328PL29 was incu-
bated with HA oligosaccharides of d.p. 12, 10 and 8, labelled at
their reducing end with a fluorescent tag, a labelled trisaccharide
was produced from d.p. 12 substrate and a labelled disaccharide
was produced from d.p. 10 and 8 substrates. These data indicate
that BT3328PL29 cleaves glycans from the reducing end (Sup-
plementary Fig. 2c, d and Supplementary discussion). We iden-
tified a conserved region of ~300 amino acids at the N-terminal of
BT3328PL29 and BT3329SGBP. This region was also shared with
SGBP-positioned genes from other PULs, which do not share a
detectable sequence similarity downstream of this ~300 amino
acid at the N-terminal region, like BT3328PL29 and BT3329SGBP.
This might constitute a ‘spacer’ domain, not homologous but,
functionally equivalent to the BACON domain found at the N-
terminal region of the surface-anchored GH5 in the xyloglucan
PUL7 and in many other SGBPs. Such domains would allow
extracellular proteins to extend out of the capsular envelope and/
or increase their mobility.
Protein–protein interactions. The interaction of the cell surface
proteins with one another was assessed by Native PAGE and
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Fig. 1 Model of glycosaminoglycan degradation by PULCS/DS/HA. a Organisation of the PULCS/DS/HA locus in Bacteroides thetaiotaomicron. b Schematic
depiction of the activity, location and specificity of PULCS/DS/HA encoded enzymes. Asterisk indicates structures were solved in this study.
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co-immunoprecipitation (Co-IP). Native PAGE demonstrated
that BT3328PL29, BT3329SGBP, BT3330SGBP and BT3331SusD
displayed no observable interaction in vitro (Supplementary
Fig. 3a, b). Co-IP data, however, demonstrated that at the cell
surface BT3328PL29, BT3329SGBP and BT3330SGBP do indeed
interact (Supplementary Fig. 3c–e). Co-IPs using anti-
BT3328PL29 and anit-BT3329SGBP antibodies revealed the pre-
sence of both BT3329SGBP and BT3330SGBP in BT3328PL29-IP
and the presence of both BT3328PL29 and BT3330SGBP in
BT3329SGBP-IP. When the BT3330SGBP precipitant was analysed
only BT3329SGBP could be observed and not BT3328PL29.
Collectively these data suggest that BT3328PL29, BT3329SGBP and
BT3330SGBP interact with each other at the bacterial cell surface
in vivo. This interaction requires either membrane attachment or
the presence of the integral membrane protein BT3332SusC.
Periplasmic glycan degradation apparatus. Biochemical analysis
of the periplasmic lyases: BT3324PL8 and BT3350PL8 are both
PL8s whilst BT4410 has recently been classified into family PL33.
BT3350PL8 is a broad specificity lyase having similar activity on
CS-A, CS-C and DS but had reduced activity on HA
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Fig. 2 HPLC product profiles of the PULCS/DS/HA encoded lyases. Peaks were identified by comparison with commercially purchased standards. The black,
blue, green and red lines represent 0, early, mid-point and late stages of the reaction time course for each enzyme (CS-A chondroitin sulfate A, DS
dermatan sulfate, CS-C chondroitin sulfate C and HA hyaluronic acid). All reactions were carried out in 50mM MES, pH 6.5, with 150mM NaCl at 37 °C.
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(Supplementary Table 2). BT3350PL8 displayed an endo mode of
action but disaccharides were observed earlier in the reaction time
course on the sulfated substrates (Fig. 2). End point assays
revealed that BT3350PL8 could cleave similar amounts of glyco-
sidic linkages in CS-A and DS but around half as much in the
GAGs CS-C and HA (Supplementary Table 2). The end products
of BT3350PL8 HA degradation are mainly of DP2, 4 and 6, with
oligos of ≥DP4 making up the majority of the population (Fig. 2).
Against CS-A the end products were mainly DP2 and DP4, whilst
against CS-C and DS a greater quantity of products >DP6 were
observed. Surprisingly, BT3350PL8 was able to cleave HA oligos
down to disaccharides (Supplementary Fig. 4a). BT3324PL8 is an
exo-acting lyase releasing exclusively disaccharides from all the
GAGs tested (Fig. 2 and Supplementary Fig. 4a). BT3324PL8
displayed its highest activity against CS-A and DS with much
reduced activities against CS-C and HA. Thus, O4 sulfation is
required for maximal activity. BT4410PL33 displayed a highly
endo-processive mode of action and displayed >100-fold pre-
ference for HA. End point assays showed the presence of sulfation
limited substrate accessibility, consistent with BT4410PL33 being
tailored towards HA (Fig. 2 and Supplementary Table 2).
Genetic analyses of the PULCS/DS/HA lyases: The contribution of
each lyase in GAG metabolism was further assessed through
growth experiments with single, double and triple genetic
mutants. Using CS-A and CS-C as the substrate, we observed
that individual PL mutants exhibited very little evidence of
growth defects; Δbt3324 exhibited a slight defect in growth rate on
CS-A (Fig. 3a). The Δbt3350/Δbt4410 showed a stronger
phenotype than Δbt3324/Δbt3350 on CS-A, whilst on CS-C both
mutants exhibited the same level of defect. This is due to O6 and/
or O2 sulfation in CS-C being inhibitory to BT4410PL33.
Whilst for CS-A the endo 4S sulfatase, BT3349-S1_274S-sulf (see
‘O-sulfatases’ section), is able to remove 4S sulfation thus
allowing enhanced activity of BT4410PL33 on CS-A (Further
detail in Supplementary discussion). The double-mutant Δbt3324/
Δbt4410 showed extremely limited or no growth on all substrates,
comparable with the triple-mutant Δbt3324/Δbt3350/Δbt4410
(Fig. 3a). The Δbt3324/Δbt4410 mutant was previously shown
to have drastically reduced BT3333-S1_156S-sulf mRNA levels in
the presence of CS13, thus, BT3350PL8 alone cannot generate
disaccharides at a significant rate as to upregulate the PUL.
BT3350PL8 must, therefore, work in conjunction with BT3324PL8
and BT4410PL33 to complete GAG catabolism to their disacchar-
ide repeating units. These data are consistent with BT3350PL8
generating new non-reducing ends for BT3324PL8 and
BT4410PL33 to act on, demonstrating an endo–exo synergy as
commonly observed in other glycan-degrading systems. When
HA is the substrate, all mutants that show a defect involved the
deletion of BT4410PL33. The Δbt4410 mutant by itself was
sufficient to cause a severe growth defect, whilst the Δbt3324/
Δbt3350 mutant showed only a minor defect, reinforcing the
critical role of BT4410PL33 as a hyaluronan specific lyase (Fig. 3a).
When DS is the growth substrate, loss of any periplasmic lyase
alone is sufficient to cause a significant defect, but loss of either
BT4410PL33 or BT3350PL8 is particularly severe (Fig. 3a). Both
enzymes have endo character indicating that the ability to cleave
linkages internally in DS is critical to its breakdown by B. theta.
All double mutants failed to grow at all on DS (Fig. 3a).
Analyses of spent supernatants from genetic mutants: Analysis
of spent supernatants from mutant growths revealed that the
Δbt3324 mutant, produced a unique product. This substrate was
purified and treated with the different lyases; only BT3324PL8
showed activity (Fig. 3b). The products were analysed by HPLC
and two peaks were identified as UA2S-GalNAc6S disaccharide
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and either UA-GalNAc4S or UA-GalNAc6S in a ratio of 3:1
(Fig. 3c). The accumulation of this substrate reveals that
BT3324PL8 is the only enzyme in B. theta capable of cleaving
regions within CS-C enriched in 2S sulfation.
O-Sulfatases. PULCS/DS/HA encodes two O sulfatases belonging
to the sulfatase subfamilies S1_27 and S1_15, the endo 4S sul-
fatase BT3349-S1_274S-sulf and the exo-acting 6S sulfatase
BT3333-S1_156S-sulf, as classified by the sulfatlas database19.
BT1596-S1_92S-sulf is located outside the PUL and belongs to
subfamily S1_9. BT3349-S1_274S-sulf and BT1596-S1_92S-sulf are
active on all O4 and O2 sulfated CS disaccharides, respectively.
This is consistent with previous work on these subfamilies20.
Whilst BT3333-S1_156S-sulf was only active on GalNAc6S and is
the first member to be functionally and structurally characterised
within the S1_15 subfamily (Supplementary Fig. 4b, c). BT3349-
S1_274S-sulf contains an SpII signal peptide (Supplementary
Table 3) and, due to its endo mode of action, it was hypothesised
that the enzyme may be attached to the extracellular surface.
Measures of the enzymatic activity at the cell surface by whole-
cell assays (see ‘Methods’) did not result in any degradation of
Δ4,5UA-GalNAc4S, a substrate for BT3349-S1_274S-sulf, even
after an incubation time of 16 h. However, when the cells were
sonicated and the disaccharide incubated with the CFE, Δ4,5UA-
GalNAc4S was completely degraded within 1 h (Supplementary
Fig. 4d). This confirms BT3349-S1_274S-sulf is a periplasmic
enzyme. BT3333-S1_156S-sulf also contains an SpII signal peptide
but whole-cell assays, using GalNAc6S, indicate that BT3333-
S1_156S-sulf is periplasmic (Supplementary Fig. 4d). This is
consistent with the requirement for the periplasmic BT3348GH88
to produce its GalNAc6S substrate (Supplementary Fig. 4d).
Crystal structures of BT3349-S1_274S-sulf and BT3333-S1_156S-sulf:
Both enzymes are α/β proteins, composed of two domains, a
larger N-terminal domain and a smaller C-terminal ‘sub-domain’
as is typical of formylglycine sulfatases21. An inactive form of
BT3349-S1_274S-sulf was crystallised with a CS-A tetrasaccharide,
but only a trisaccharide of Δ4,5UA-GalNAc4S-GlcA could be
modelled (Fig. 4a, b, Supplementary Fig. 5a). Subsite nomen-
clature for carbohydrate sulfatases is such that an S site denotes
the position of the labile sulfate, which is attached to a 0 subsite
sugar. Additional subsites then increase in number toward the
reducing end of the glycan, i.e. +1, +2, etc., and decrease in
number toward the non-reducing end of the glycan, i.e. −1, −2,
etc22. Electron density for the −1, 0 and S subsites was well
ordered whilst the +1 GlcA was partially disordered and makes
no interactions with the protein. A detailed description of the
mutants is provided in the supplementary discussion (Supple-
mentary Table 5 and Supplementary Fig. 5e). The endo activity of
BT3349-S1_274S-sulf is conferred by an ‘opening up’ of either side
of the 0 subsite, allowing glycan extension in both the +1 and −1
direction. Structural comparison of HGM, marine and human
carbohydrate sulfatases reveals that the linker between β-strand 4
and α-helix 5 is extended, and/or alterations of the C-terminal
subdomain (Fig. 4c–h) commonly occur in the exo sulfatases,
precluding endo activity. In BT3333-S1_156S-sulf, however,
occlusion of potential positive subsites is achieved by an insertion
between β-strand 3 and α-helix 4. These features would also
prevent extension of the sugar chain beyond the 0 subsite in the
endo sulfatases.
The structure of BT3333-S1_156S-sulf was solved in complex
with GalNAc6S and displays a pocket topology (Fig. 5a,
Supplementary Fig. 5b). The 0 subsite is made up primarily of
polar interactions (Fig. 5b). The axial O4 of the GalNAc (the
unique difference of Gal versus Glc-configured substrates, the
latter having an equatorial O4) coordinates with Oδ2 of D173 and
NH1 of R174 (for further interactions see Supplementary
discussion). These interactions probably drive the specificity for
GalNAc versus GlcNAc substrates. R174 also coordinates with O1
and the endocyclic ring oxygen through NH2 whilst O3 interacts
with the Nε2 of H225A (Fig. 5b). Comparing overlays of BT3333-
S1_156S-sulf with BT4656-S1_116S-sulf, the GlcNAc6S sulfatase
encoded by PULHep, reveals that the two substrates bind
perpendicular to one another and thus no interactions are
spatially conserved (Fig. 5c). Despite this both enzymes use an
Asp and Arg to bind O4 and a His to co-ordinate O3. In BT3333-
S1_156S-sulf these residues are from the N-terminal side of the
protein (D173, R174 and H225) whilst in BT4656-S1_116S-sulf
they are from the C-terminal side of the protein (D361, R363 and
H447). In addition, when compared with GALNS (4FDJ), the
human 6S GalNAc sulfatase, there is no conservation of the
sugar-binding residues between the two proteins (Supplementary
Fig. 5c–e). Currently no substrate complex of GALNS exists and
the specificity determinants remain undescribed.
GH88 enzyme. The BT3348GH88 is an essential enzyme for CS
metabolism13. BT3348GH88 showed a similar catalytic efficiency
against Δ4,5UA-GalNAc, Δ4,5UA-GalNAc6S and Δ4,5UA-
GlcNAc but was inactive against Δ4,5UA2S-GalNAc, Δ4,5UA-
GalNAc4S, Δ4,5UA-GalNAc4S6S and Δ4,5UA2S-GalNAc4S6S
(all β1,3 linked). BT3348GH88 was also inactive on the β1,4 linked
heparin disaccharide Δ4,5UA-GlcNAc (Supplementary Table 5).
BT3348GH88 can tolerate O6 sulfation but not O2 or O4 sulfation,
and is specific for the β1,3 linkage but has no preference for
GlcNAc or GalNAc at its +1 subsite.
Growth and bioinformatic analyses of gut Bacteroides species.
Eleven Bacteroides species were grown on each GAG as sole
carbon source and classified as either strong, intermediate or non-
utilisers. For CS-A and CS-C B. theta, B. ovatus, B. eggerthii,
B. xylanisolvens and B. plebeius were all strong utilisers whilst
B. caccae, B. cellulosilyticus, and B. intestinalis demonstrated
intermediate growth. When DS was the substrate there was a shift
in classifications compared with CS-A and CS-C. B. eggerthii and
B. plebeius switched to being non-utilisers whilst B. intestinalis
was classified as a strong utiliser. When HA was the substrate
B. ovatus and B. eggerthii out performed all other strains. Only
B. theta grew as fast but was classified as intermediate due to a
~20% lower final OD600 nm (Fig. 6).
Orthologous proteins were searched to identify PULCS/DS/HA
relatives in the eleven species. The three strains B. vulgatus,
B. dorei and B. fragilis lack PULCS/DS/HA and only harbour a
BT3348GH88 orthologue (and a separated BT4410PL33 in B.
fragilis). Consistently, all three showed no growth on any GAGs.
We observed BT3328PL29-BT3330SGBP were more rapidly diver-
ging and completely lost in B. cellulosilyticus, B. intestinalis and B.
eggerthii. However, no impact on growth was observed, consistent
with Δbt3328 mutant growth data. The only genetic differences
with potential growth impacts were the loss of BT4410PL33
orthologues in both B. eggerthii and B. plebeius (which
additionally lacks a BT3350PL8 orthologue). The importance of
BT4410PL33 for B. theta growth on DS and HA (i) explains the
switch of B. eggerthii and B. plebeius from strong utilisers on CS-
A and CS-C to non-utilisers on DS; (ii) suggests that alternative
pathways for HA catabolism exist in these organisms compared
with B. theta. B. eggerthii notably outcompeted most other strains
on CS-A, CS-C and HA. This could mean members of the PL35
(BACPLE_02279, BACEGG_01448) or PL37 (BACEGG_00231)
which are active on GAGs16,23 and not present in B. theta, are
contributing to this enhanced growth.
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Fig. 4 Structural depictions of BT3349-S1_274S and its comparison with other endo and exo sulfatases. a Cartoon representation of BT3349-S1_274S-sulf
ramped blue to red from its N- to C-terminus; b stick representation of binding site interactions with the protein in green and the bound trisaccharide yellow;
c surface representation of BT3349-S1_274S-sulf showing how the +1 and −1 ends of the trisaccharide are free to be extended; d overlays of surface
representations of BT3349-S1_274S-sulf and a cartoon of the marine endo 4S ι-carrageenan sulfatase (PsS1_19A). CS and ι-carrageenan oligosaccharides are
shown in yellow and cyan, respectively. e Overlay of a surface of BT3349-S1_274S-sulf with a cartoon of the exo-sulfatase BT1596-S1_92S-sulf. f Overlay of a
surface of BT3349-S1_274S-sulf with a cartoon of the exo-sulfatase BT3333-S1_156S-sulf. g Overlay of a surface of BT3349-S1_274S-sulf with a cartoon of the
human exo-sulfatase 1FSU4S-sulf. h Overlay of a surface of BT3349-S1_274S-sulf with a cartoon of the human exo-sulfatase 5FQL2S-sulf. All cartoon
representations are ramped blue to red from their N- to C-terminus.
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Comparative genomic analyses on a thousand Bacteroidetes
species revealed that PULCS/DS/HA is largely associated with the
Bacteroides genus but not ubiquitous. Different sections are
variably conserved and may have accessory interest, like the
aforementioned BT3328PL29-BT3330SGBP region (Supplementary
Fig. 6 and Supplementary Table 5). Also, many insertions are
observed which separate the PUL elements into several islands,
without impairing the PUL activity, according to growth data.
Examples span from the three-gene insertion specific to B. theta
strains (BT3344-BT3347 that includes an unrelated susCD pair)
to hundreds of genes separating B. plebeius orthologues into three
genomic regions (Supplementary Fig. 6). Thus, orthologue
conservation is more relevant over a tight organisation when
predicting growth. Searches beyond the human gut Bacteroides
genus reveal species having all required orthologues for growth in
the Chitinophaga, Cytophaga and Sphingobacteria classes (some
from human skin, chicken gut and soil environments). Notably, a
tightly packed PUL was found in Propebela bergensis that even
incorporates BT4410PL33 within the core PUL (Supplementary
Fig. 6).
Discussion
PULCS/DS/HA performs a highly co-ordinated degradation of
GAGs but in a contrasting way to the previously described
PULHep, which degraded H/HS. PULHep encodes four PLs all of
which displayed significant processivity with variable sulfation
tolerances24. PULCS/DS/HA, however, utilises endo–exo synergy in
the periplasm between BT3350PL8 and BT3324PL8 for the
degradation of CS-A, CS-C and DS. The PUL also deploys an
endo-acting O4 sulfatase, BT3349-S1_274S-sulf, the rationale
behind its endo mode of action, however, is not obvious. BT3349-
S1_274S-sulf may enable BT4410PL33 to contribute to the degra-
dation of CS-A and DS, where O4 sulfation would be inhibitory.
A surprising finding was the important role BT4410PL33 plays in
DS metabolism within the Bacteroides genus, a result that could
not be predicted. The anchoring of BT3349-S1_274S-sulf to the
periplasmic side of the membrane may localise it close to the
SusC and where it could remove O4 sulfation as glycans enter
the periplasm. Alternatively, it could be localised close to
BT3334HTCS and BT3348GH88, neither of which can utilise O4
sulfated disaccharides13 and are also membrane associated. This
may allow O4 sulfated disaccharides to be desulfated close to the
HTCS before BT3348GH88 can degrade them. BT1596-S1_92S-sulf
must remove any 2S sulfation present for BT3348GH88 to act.
BT3333-S1_156S-sulf then removes the O6 sulfation of GalNAc
leaving the final degradation products as GalNac and 4-deoxy-L-
threo-5-hexosulose-uronate. For HA metabolism BT4410PL33 is
the only lyase required due to its endo-processive mode of action,
and after BT3348GH88 has acted the final products would be
GlcNAc and 4-deoxy-L-threo-5-hexosulose-uronate. 4-deoxy-L-
threo-5-hexosulose-uronate is able to feed directly into metabo-
lism in the cytoplasm25 whilst both GlcNAc and GalNAc
require phosphorylation before further metabolism. In contrast to
PULHep, which encodes the GlcNAc kinase BT4654ROK,
PULCS/DS/HA does not encode for any kinases. Therefore, phos-
phorylation of GalNAc and GlcNAc, must be completed by
constitutively active kinases. Support for a constitutively active
GlcNAc kinase is that deletion of BT4654ROK in PULHep has no
growth defect on H/HS24. In addition, no differentially expressed
kinases are observed during CS growth.
Although the extracellular glycan apparatus appears to confer
no advantage in mono-cultured systems, it may be important
in a multi-organism, competitive, environment. When B. theta,
B. caccae and B. cellulosilyticus were co-cultured on CS for
5 days it was observed that B. cellulosilyticus CFUs were
≤100-fold lower than B. theta and B. caccae and ≤100 than
B. cellulosilyticus when mono-cultured26. B. cellulosilyticus lacks
any surface glycan apparatus whilst it is present in both B. theta
and B. caccae.
Goodman et al.27 identified, through transposon mutagenesis,
genes in B. theta which were important for colonisation of
the mouse gut. Strains with insertion in bt3348 showed a
marked decrease in output compared with input. In addition,
when mice were colonised with an artificial microbiome of
multiple Bacteroidetes species (including transposon mutagen-
ised B. theta strains), B. theta strains with insertions in bt3330
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Fig. 5 Structural depictions of BT3333-S1_156S-sulf and it comparison
with BT46566S-sulf. a A close up of a surface representation showing the
pocket topography of BT3333-S1_156S-sulf; b stick representations of the
binding site interactions with the protein in green and GalNAc6S in yellow;
c overlay of BT3333-S1_156S-sulf in complex with GalNAc6S (green) and
BT4656-s1-116S-sulf in complex GlcNAc6S (cyan).
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and BT3349-S1_27 were much reduced in bacterial number
compared with monocolonized mice. Thus, CS, DS and HA
metabolism are under increased selection pressure in a com-
petitive environment with other Bacteroidetes species. Con-
versely, bt3328 mutants showed increased bacterial numbers,
compared with monocolonized mice, when colonised with other
Bacteroidetes, Firmicutes and Actinobacteria.
Indomethacin release, in the gut, from cross-linked CS is
dependent upon biodegradation by the caecal contents28. The
detailed biochemical analysis of the extracellular glycan apparatus
in this study may facilitate strategies to more tightly control drug
release to the digestive tract using cross-linked CS. The structural
data of BT3349-S1_274S-sulf shows how endo-sulfatase activity
has evolved and could be used to predict/guide engineering of
sulfatase function. The active site of BT3333-S1_156S-sulf reveals
the specificity determinants for Gal over Glc-configured sub-
strates when compared with the GlcNAc6S sulfatase BT4656-S1-
116S-sulf. These data highlight how much more highly variable the
active sites of related sulfatase are than could be predicted from
the nature of their respective substrates. The knowledge of the
highly variable nature of the glycone-binding site of sulfatases
may help design future glycosulfate-specific inhibitors. This is of
timely relevance because of the recently revealed role of sulfatase
action in eliciting colitis in a colitis sensitive mouse model17.
Conclusions
The data presented here reveal how the HGM has evolved a core
GAG utilisation machinery (PULCS/DS/HA) to target diverse GAGs
in the human gut. PULCS/DS/HA components included orphan,
physically connected and constitutively active genes with com-
plementary and in some cases unique activities which together
enable the complete metabolism of diverse GAGs. PULCS/DS/HA
components are widely conserved in Bacteroides and thus pre-
sents a general model of CS, DS and HA metabolism, which can
be applied to other members of the HGM.
Methods
Sources of carbohydrates. Carbohydrates were from Sigma, carbosynth or Dextra
Laboratories. All other chemical reagents were purchased from Sigma.
Bacteroides culture and genetic manipulation: Various Bacteroides strains and
B. theta VPI-5482 were cultured anaerobically in a Whitley A35 Workstation
(Don Whitley) at 37 °C in either tryptone yeast extract glucose medium or
minimal medium (MM) containing GAGs (described below). B. theta strains
containing specific gene deletions or inactivated versions of enzymes were made
by counter selectable allelic exchange as described below18. All genetic mutants,
except Δbt3328, were provided by Dr Guy E. Townsend and Prof. Eduardo
Groisman13. The in frame mutants were generated using counter selectable
allelic exchange29. Briefly, 1-kb fragments either side of the target gene were
cloned, ‘stitched together’ by PCR, and ligated into the pExchange plasmid
using SalI/XbaI sites. This recombinant plasmid was then conjugated into a tdk−
version of B. theta (referred to as wildtype (WT) in this study) using the S17-1 λ
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Fig. 6 Growth curves of 11 bacteroides species on CS-A, DS, CS-C and HA. The different species were divided into strong, intermediate and non-utilisers
based on analysis of growth curve rates and final optical densities. Data represent technical triplicates and source data are provided in the source data file
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pir Escherichia coli strain. Initial homologous recombination, plasmid insertion,
is selected for using erythromycin resistance. Then a second low-frequency
recombination event, exclusion of the pExchange plasmid from the genome, is
selected for using FUdR containing plates. In frame deletion mutants were
detected and checked using PCR and sequencing. Insertional mutations were
constructed by cloning a 750-bp sequence from the gene to be disrupted into the
pKNOCK tet vector, followed by its introduction into the B. theta chromo-
some30. Growth of the WT and mutants was measured on glycans by mixing
the autoclave-sterilised polysaccharides (0.5% final) with minimal media (per
100 ml was: 0.1 g of Ammonium sulfate and sodium carbonate, 0.05 g cysteine,
10 ml 1 M potassium phosphate pH 7.2, 0.1 ml of 1 mg ml−1 vitamin K, 1 ml of
0.4 mg ml−1 iron sulfate, 0.4 ml of 0.25 mg ml resazurin, 0.05 ml of 0.01 mg ml−1
vitaminB12 and 5 ml of mineral salts for defined media) and monitoring growth
continuously in 96-well plates using a Biotek Epoch plate reader. Growth curves
presented are averages of three technical replicates.
Co-immunoprecipitation and western blotting: Bacterial cells were collected in
the mid-exponential phase and bacterial pellets were resuspended in the lysis buffer
(50 mm Tris, pH 7.5, 150 mm NaCl, 0.2 mm Na3VO4, 1% Nonidet P-40 alternative,
1 mm PMSF, 1 mm DTT, and 1× protease inhibitors (Roche Applied Science)).
Lysates were sonicated followed by incubation with 1 μg of antibodies as indicated
for 16 h at 4 °C, antibodies were pulled down using protein G-Sepharose beads.
Samples were then run on 12.5% SDS-PAGE gels, then transferred to a nitro-
cellulose membrane using standard buffers. Both primary and secondary antibodies
were used as 1/1000 dilutions in 5% milk powder. The secondary antibody was
mouse anti-rabbit IgG-HRP (sc-2357). Normal mouse IgG (sc-2025) was used as a
negative control. Both antibodies were purchased from santa-cruz.
Microscopy: GAG grown cells were harvested at mid-exponential phase and fixed
for 90 min in formalin (10% formaldehyde in PBS buffer). Primary Ab was incu-
bated 1/500 for 2 h at room temperature (RT), followed by incubation with the
secondary Ab (Santa Cruz goat anti-rabbit FITC) at 1/500 at RT for 1 h. Cells were
immobilised for the microscopy by transfer on 1.2% agarose/H2O pads. Fluores-
cence microscopy was carried out with Nikon Eclipse Ti equipped with Nikon Plan
Apo 100×/1.40 NA phase contrast objective, Prime sCMOS camera (Teledyne
Photometrics) and Lambda LS Xenon-arc lamp (Sutter Instruments), and Chroma
49002 filter set (Chroma Technology). Images were acquired with Metamorph 7.7
(Molecular Devices) and analysed with Fiji31.
Whole-cell assays. Whole-cell assays are a direct readout of cell surface activity.
After washing with PBS there is no longer any sugar transport by the TonB
dependent SuSC transporter. Therefore, product profiles and activities of surface
enzymes can be assessed. B. theta was grown in 5 mL MM with 1% (wt/vol)
appropriate GAG as the sole carbon source to mid-exponential phase in glass test
tubes. Cells were harvested by centrifugation at 5000 × g for 10 min at RT and
washed in 5 mL PBS (pH 7.2) before being resuspended in 1 mL PBS. Washed cells
were assayed against 10 mgmL−1 of the appropriate substrate at 37 °C for up to
24 h. Assays were analysed by thin layer chromatography (TLC), and 2 μL each
sample was spotted onto silica plates and resolved in butanol:acetic acid:water
(2:1:1) running buffer. The plates were dried, and the sugars were visualised using
diphenylamine stain.
Recombinant protein production. Genes were amplified by PCR using the
appropriate primers and the amplified DNA cloned in pET28a using BamHI/XhoI
or NheI/XhoI restriction sites generating constructs with either N- or C-terminal
His6 tags (Supplementary Table 7). Recombinant genes were expressed in E. coli
strains BL21 (DE3) or TUNER (Novagen), containing the appropriate recombinant
plasmid, and cultured to mid-exponential phase in LB supplemented with
50 μg/mL kanamycin at 37 °C and 180 rpm. Cells were then cooled to 16 °C, and
recombinant gene expression was induced by the addition of 0.1 mM isopropyl β-
D-1-thiogalactopyranoside; cells were cultured for another 16 h at 16 °C and
180 rpm. The cells were then centrifuged at 5000 × g and resuspended in 20 mM
Hepes, pH 7.4, with 500 mM NaCl before being sonicated on ice. Recombinant
protein was then purified by immobilised metal ion affinity chromatography using
a cobalt-based matrix (Talon, Clontech) and eluted with 100 mM imidazole. For
the proteins selected for structural studies (BT3333-S1_156S-sulf and BT3349-
S1_274S-sulf), another step of size-exclusion chromatography was performed using
a Superdex 16/60 S200 column (GE Healthcare), with 10 mM Hepes, pH 7.5, and
150 mM NaCl as the eluent, and they were judged to be ≥95% pure by SDS-PAGE.
Protein concentrations were determined by measuring absorbance at 280 nm using
the molar extinction coefficient calculated by ProtParam on the ExPasy server
(web.expasy.org/protparam/).
Isothermal Calorimetry (ITC). The affinity of BT3329SGBP, BT3330SGBP and
BT3331SusD for oligo- and polysaccharides was quantified by ITC using a Microcal
VP calorimeter. The protein sample (50 μM), stirred at 394 rpm in a 1.4-mL
reaction cell, was injected with 26 × 10-μL aliquots of ligand. Titrations were car-
ried out in 50 mM Tris-HCl buffer, pH 8.0, at 25 °C. Integrated binding heats
minus dilution heat controls were fit to a single set of sites binding model to derive
KA, ΔH and n (number of binding sites on each molecule of protein) using
Microcal Origin v7.0. The molar concentration of binding sites present in poly-
saccharides for BT3329SGBP was determined by altering the concentration of ligand
used for regression of the isotherm until the fit yielded a value of 1 for n. For
BT3330SGBP and BT3331SusD n was fixed to 1 and a ligand concentration of 2 mM
was used.
Enzyme assays. All assays, unless stated, were carried out in 50 mMMES, pH 6.0,
or Bis-Tris propane, pH 6.5, with 150 mM NaCl at 37 °C. PL activity was mon-
itored continuously at A235 nm by the formation of the carbon double bond gen-
erated through the enzymes beta elimination mechanism of action. BT3334GH88
glucuronyl hydrolase activity was determined by monitoring loss of signal at
A235nm. The kinetic parameters of BT3349-S1_274S were monitored via a con-
tinuous linked assay using BT3334GH88 and UA-GalNAc4S as the substrate.
BT3334GH88 will only hydrolyse UA-GalNAc4S after it has been converted to UA-
GalNAc by BT3349-S1_274S-sulf and thus loss of sulfation can be monitored
indirectly by loss of signal at A235nm caused by BT3334GH88 hydrolysing any UA-
GalNAc produced. The ability of BT3333-S1_156S-sulf, BT3349-S1_274S-sulf and
BT1596-S1_92S-sulf to remove O2, O4 and O6 sulfation, respectively, from unsa-
turated CS disaccharides was also monitored qualitatively by TLC. Reaction profiles
of PLs and sulfatase digestion of GAGs were monitored by HPAEC using an AD25
or a VWD, Thermofisher, absorbance detector at A235nm to detect the
carbon–carbon double bond products, with H2O, pH 3.5, as the eluent and a
second eluent of H2O with 3 M NaCl used to generate a linear NaCl gradient to
100% over 90 min. All enzymatic assays were performed in technical triplicate.
Labelling of glycans: Labelling with 2-aminobenzamide acid (2-AB) was per-
formed using the ludgerTag 2-AB glycan labelling kit. Briefly, DMSO was added to
acetic acid in a 0.75:1 ratio and 100 μl added to 5 mg of 2-AB. This mixture is then
added to the reductant sodium cyanoborohydride and when fully dissolved 5 μl was
added to 50 nmol of dried HA dodecasaccharide. The reaction was left at 65 °C for
~3 h. After labelling samples were cleaned up using the provided spin columns.
Labelling of HA octasaccharide and decasaccharide was carried out by creating a
saturated solution of 7-aminonapthalene-1,3-disulfonic acid (ANDSA) in for-
mamide and mixing this with 500 μg of dried glycan. The mixture was left over-
night at RT and the labelled glycans used the next day in a 1/5 dilution versus
enzyme buffer. Saccharides labelled using the UV fluorescent tag, ANDSA were run
on 33% acrylamide tris-acetate gels with tris-MES running buffer. Gels were viewed
after removal from the glass plates on a UV transilluminator32.
Crystallisation of BT3333-S1_156S-sulf and BT3349-S1_274S-sulf. After purification,
BT3333-S1_156S-sulf and BT3349-S1_274S-sulf were carried forward in the same
eluent as used for the size-exclusion chromatography. All proteins were then con-
centrated in centrifugal concentrators with a molecular mass cutoff of 30 kDa. Sparse
matrix screens were set up in 96-well sitting drop TTP Labtech plates (400-nL
drops). Initial BT3333-S1_156S-sulf apo crystals were obtained at 20mg/mL in 20%
PEG 3350 and KCl. For BT3349-S1_274S-sulf ligand-bound initial hits were obtained
at 20mgmL−1 in 20% PEG 3350 and 0.2M K acetate. BT3349-S1_274S-sulf crystals
were soaked overnight with 10mM of a CS tetrasaccharide prior to fishing.
BT3333-S1_156S-sulf ligand-bound forms were crystallised at 20mgmL−1 with
10mM GlaNAc6S in 30% PEG 4000, 200mM MgCl2, and 0.1M Tris, pH 8.5. All
crystals were cryo-cooled with the addition of 20% PEG 400. Data were collected at
Diamond Light Source (Oxford) on beamlines I24 and I04-1 (0.98 Å) at 100 K. The
data were integrated with XDS33 and scaled with Aimless34,35. Five percent of
observations were randomly selected for the Rfree set. The phase problem was solved
by molecular replacement using the program automated molecular replacement
server Balbes36 for BT3349-S1_274S-sulf. The phase problem for BT3333-S1_156S-sulf
was initially solved using Molrep37 and BT1624 (unpublished structure) as the search
model. This gave a partial solution, which could not be fully solved due to tNCS and/
or twinning. A good enough model of BT3333-S1_156S-sulf was constructed to be
used to solve the phase problem for subsequent collected data, which showed no
tNCS and/or twinning defects. Models underwent recursive cycles of model building
in Coot38 and refinement cycles in Refmac539. The models were validated using
Coot38 and MolProbity40. Structural Figures were made using Pymol (the PyMOL
Molecular graphics system, Version 2.0 Schrodinger, LLC) and all other programmes
used were from the CCP4 suite41. The data processing and refinement statistics are
reported in Supplementary Table 6.
Site-directed mutagenesis. Site-directed mutagenesis was conducted using the
PCR-based QuikChange kit (Stratagene) according to the manufacturer’s instruc-
tions using the appropriate plasmid as the template and appropriate primer pairs.
Comparative genomics analysis. Similar PULs were searched in >900 Bacter-
oidetes genomes as follows. First, we identified orthologous proteins to
PULCS/DS/HA based on reciprocal best BlastP results between B. theta and each
species. Orthologous proteins were mapped to their PUL predictions in PULDB to
identify loci gathering several orthologues. For the 11 species tested for growth,
PUL predictions were manually refined (enlarged) for boundaries to cover the
whole PULCS/DS/HA region which included variable insertions between the core
operon and BT3324 or BT3349-S1_27-BT3350 orthologues.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The datasets generated during and/or analysed during the current study are available
from the corresponding author on reasonable request. Protein structure data concerned
with the structures solved in this work, 6S21 and 6S20, have been deposited with the
protein data bank (PDB). Data underlying Figs. 3, 6, Supplementary Figs. 2–4 and
Supplementary Tables 2 and 4 have been provided in a source data folder.
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